1 |
Ischemic Optic Neuropathy After Administration of a SARS-CoV-2 Vaccine: A Report of 2 Cases
|
|
|
|
In: Am J Case Rep (2022)
|
|
BASE
|
|
Show details
|
|
2 |
Vitreous and Optic Nerve Infiltration of an Adrenal B Lymphoma
|
|
|
|
In: Case Rep Ophthalmol (2021)
|
|
BASE
|
|
Show details
|
|
3 |
Plasma Rich in Growth Factors (PRGF) Increases the Number of Retinal Müller Glia in Culture but Not the Survival of Retinal Neurons
|
|
|
|
In: Front Pharmacol (2021)
|
|
BASE
|
|
Show details
|
|
4 |
Remote screening of retinal and optic disc diseases using handheld nonmydriatic cameras in programmed routine occupational health checkups onsite at work centers
|
|
|
|
In: Graefes Arch Clin Exp Ophthalmol (2020)
|
|
BASE
|
|
Show details
|
|
5 |
Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema
|
|
|
|
In: Front Immunol (2020)
|
|
BASE
|
|
Show details
|
|
6 |
Paraneoplastic Focal Outer Retinitis and Optic Neuropathy in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5, Anti-HU and Anti-Amphiphysin Antibodies
|
|
|
|
In: Case Rep Ophthalmol (2020)
|
|
BASE
|
|
Show details
|
|
7 |
Current ophthalmology practice patterns for syphilitic uveitis
|
|
|
|
BASE
|
|
Show details
|
|
8 |
Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
|
|
|
|
BASE
|
|
Show details
|
|
9 |
Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
|
|
|
|
BASE
|
|
Show details
|
|
10 |
Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study
|
|
|
|
BASE
|
|
Show details
|
|
11 |
Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro
|
|
|
|
BASE
|
|
Show details
|
|
12 |
Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study
|
|
|
|
BASE
|
|
Show details
|
|
13 |
Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study
|
|
|
|
BASE
|
|
Show details
|
|
14 |
Dabrafenib for cutaneous melanoma infiltrating the vitreous: regression of metastasis and occurrence of uveitis as a secondary effect
|
|
|
|
BASE
|
|
Show details
|
|
15 |
Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis
|
|
|
|
BASE
|
|
Show details
|
|
16 |
Development of an activity disease score in patients with uveitis (UVEDAI)
|
|
|
|
BASE
|
|
Show details
|
|
17 |
Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
|
|
|
|
BASE
|
|
Show details
|
|
18 |
INSULIN RESISTANCE AND DIABETIC MACULAR EDEMA IN TYPE 2 DIABETES MELLITUS
|
|
|
|
In: ISSN: 0007-1161 ; EISSN: 1468-2079 ; British Journal of Ophthalmology ; https://hal.archives-ouvertes.fr/hal-00557345 ; British Journal of Ophthalmology, BMJ Publishing Group, 2010, 94 (9), pp.1230. ⟨10.1136/bjo.2009.171702⟩ (2010)
|
|
Abstract:
International audience ; Objective: Evaluate the association between insulin resistance and diabetic macular edema in type 2 diabetes Methods: Cross-sectional study. Type 2 diabetes patients who agreed to undergo blood sample extraction were enrolled. Patients who had received treatment for macular edema within the past 3 months and those with other retinal diseases were excluded. The following data were recorded: age, sex, time of diabetes evolution, HbA1C, ophthalmologic and systemic treatment, and lens status. Optic coherence tomography was performed to determine the morphologic patterns of macular edema. Insulin resistance was established on a McAuley index of <6.3 and fasting insulin levels of >16 mU/L. Results: 177 eyes from 90 patients were included; 27.1% of eyes were from insulin-resistant patients. There were no differences in age, time of evolution, sex, HbA1C or lens status between insulin resistant and nonresistant patients Insulin resistant patients were more likely to have exogenous insulin therapy (P<0.05; OR=3.8). An association was found between diabetic cystoid macular edema and resistance (Fisher exact test P=0.007; OR=2.53, 95% CI: 1.52-4.2). There were no associations between insulin resistance and the other morphologic patterns of edema. Patients undergoing insulin therapy were found to have an association with a diffuse retinal thickening pattern on OCT (P=0.036; OR=1.4). However, no association was found between insulin therapy and the presence of cystoid macular edema. Conclusions: The findings of this study indicate a relationship between insulin resistance and cystoid macular edema, which is not related to the use of insulin. Insulin treatment was associated with diffuse macular edema.
|
|
Keyword:
Macula
|
|
URL: https://hal.archives-ouvertes.fr/hal-00557345/file/PEER_stage2_10.1136%252Fbjo.2009.171702.pdf https://hal.archives-ouvertes.fr/hal-00557345 https://hal.archives-ouvertes.fr/hal-00557345/document https://doi.org/10.1136/bjo.2009.171702
|
|
BASE
|
|
Hide details
|
|
19 |
Insulin resistance and diabetic macular oedema in type 2 diabetes mellitus
|
|
|
|
BASE
|
|
Show details
|
|
20 |
Insulin resistance and diabetic macular oedema in type 2 diabetes mellitus
|
|
|
|
BASE
|
|
Show details
|
|
|
|